CI
Cipla
CIPLA.NS·NSEMumbai INFounded 193525,000 employees
Large CappharmaPublicRespiratoryOncologyInfectious Disease
Platform: Complex Gen
Market Cap
$14B
All Drugs
5
Clinical Trials
11
Failed / Terminated
4
FDA Approved
1
Stock Price & Catalysts (CIPLA.NS)
Loading CIPLA.NS stock data...
Drug Pipeline (5 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Datozasiran | CIP-994 | NDA/BLA | 2 | RET | FLSchizophrenia | ||
| CIP-213 | CIP-213 | Approved | 4 | Nectin-4 | Gastric CaAtopic Derm | ||
| Zenozasiran | CIP-4431 | Preclinical | 2 | BET | PsAFSGS | ||
| Tezesertib | CIP-5599 | Phase 1 | 1 | BCMA | Alzheimer'sIgAN | ||
| CIP-2846 | CIP-2846 | Phase 3 | 2 | MALT1 | WMAS |
SEC Filings & Financial Documents
SEC filings are not available for NSE-listed companies.
Cipla trades on NSE (IN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (9)